Nivolumab and Ipilimumab Combination Immunotherapy for Patients with Metastatic Collecting Duct Carcinoma

Collecting duct carcinoma (CDC) is a rare, extremely aggressive form of renal cancer. Recently, immune checkpoint inhibitors (ICI), anti-programmed death-1 (PD-1) antibody, and anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) antibody were approved for use against metastatic renal cell carc...

Descripción completa

Detalles Bibliográficos
Autores principales: Danno, Tetsuya, Iwata, Shohei, Niimi, Fusako, Honda, Sachi, Okada, Haruka, Azuma, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270715/
https://www.ncbi.nlm.nih.gov/pubmed/34306793
http://dx.doi.org/10.1155/2021/9936330

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270715/
https://www.ncbi.nlm.nih.gov/pubmed/34306793
http://dx.doi.org/10.1155/2021/9936330

Ejemplares similares